Lentiviral mediated gene delivery as an effective therapeutic approach for Parkinson disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lentiviral mediated gene delivery as an effective therapeutic approach for Parkinson disease
Authors
Keywords
Parkinson disease, Lentiviral vector, Blood brain barrier
Journal
NEUROSCIENCE LETTERS
Volume 750, Issue -, Pages 135769
Publisher
Elsevier BV
Online
2021-02-24
DOI
10.1016/j.neulet.2021.135769
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune Responses to Viral Gene Therapy Vectors
- (2020) Jamie L. Shirley et al. MOLECULAR THERAPY
- Fibroblast growth factor 21 and autophagy: A complex interplay in Parkinson disease
- (2020) Violina Kakoty et al. BIOMEDICINE & PHARMACOTHERAPY
- Potential of transposon-mediated cellular reprogramming towards cell-based therapies
- (2020) Dharmendra Kumar et al. World Journal of Stem Cells
- Targeting microglia with lentivirus and AAV: Recent advances and remaining challenges
- (2019) Margaret E. Maes et al. NEUROSCIENCE LETTERS
- Modulation of immune responses in lentiviral vector-mediated gene transfer
- (2018) Andrea Annoni et al. CELLULAR IMMUNOLOGY
- Gene Therapy for Parkinson’s Disease, An Update
- (2018) Tobias M. Axelsen et al. Journal of Parkinsons Disease
- Effects of α-synuclein on axonal transport
- (2017) Laura A. Volpicelli-Daley NEUROBIOLOGY OF DISEASE
- Neuroprotective effects of lentivirus-mediated cystathionine-beta-synthase overexpression against 6-OHDA-induced parkinson's disease rats
- (2017) Wei-lan Yin et al. NEUROSCIENCE LETTERS
- Translation of Human-Induced Pluripotent Stem Cells
- (2016) Nazish Sayed et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Optimizing Transgene Configuration and Protein Fusions to Maximize Dopamine Production for the Gene Therapy of Parkinson's Disease
- (2016) Hannah J. Stewart et al. Human Gene Therapy Clinical Development
- Production of lentiviral vectors
- (2016) Otto-Wilhelm Merten et al. Molecular Therapy-Methods & Clinical Development
- α-Synuclein, a chemoattractant, directs microglial migration via H2O2-dependent Lyn phosphorylation
- (2015) Shijun Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Non-viral reprogramming of fibroblasts into induced pluripotent stem cells by Sleeping Beauty and piggyBac transposons
- (2014) Thirumala R. Talluri et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
- (2014) Stéphane Palfi et al. LANCET
- Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant
- (2014) Marc Folcher et al. Nature Communications
- Calcium Entry and -Synuclein Inclusions Elevate Dendritic Mitochondrial Oxidant Stress in Dopaminergic Neurons
- (2013) D. I. Dryanovski et al. JOURNAL OF NEUROSCIENCE
- Interventional MRI-guided Putaminal Delivery of AAV2-GDNF for a Planned Clinical Trial in Parkinson's Disease
- (2011) R Mark Richardson et al. MOLECULAR THERAPY
- Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
- (2010) Marina Cavazzana-Calvo et al. NATURE
- Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
- (2008) Salima Hacein-Bey-Abina et al. JOURNAL OF CLINICAL INVESTIGATION
- Dual-promoter lentiviral vectors for constitutive and regulated gene expression in neurons
- (2007) Sergio Gascón et al. JOURNAL OF NEUROSCIENCE METHODS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now